Chris Hill
Analyst · Stifel. Please proceed
Thanks, Larry. Before we review the financial performance for the quarter, the guidance we gave on our last call and past calls specifically excluded the impact of any FX gains or losses and assumed an effective tax rate of 20%. So accordingly, our discussion today excludes any foreign exchange gain or loss for current and prior periods. The comparison periods for the first quarter of 2024 and second quarter of 2023 also include items that were discussed in those calls and highlighted in our earnings release for those periods. These items have also been excluded from our discussion of the financial results today. You can find a summary of those items in the tables attached to our press release for the second quarter of 2024. So, now looking at the income statement. Revenue was $130.6 million in the second quarter, a slight increase from $129.6 million in the prior quarter and $127.9 million in the prior year second quarter. Sequentially, increased demand in both the U.S. and certain international regions for reservoir rock and fluid analytical programs was partially offset by lower completion diagnostic services and completion product sales in international markets. Of this revenue, service revenue, which is more international, was $96.3 million for the quarter, flat sequentially and up over 3% from last year. Demand for our laboratory-based reservoir rock and fluid analytical programs, continues to improve and is expected to continue growing globally with the stronger growth in certain international regions. However, the sequential growth was offset by a slightly lower level of completion diagnostic services in the U.S. and continued disruptions in some of the international regions, where assay services continue to be impacted by the ongoing geopolitical conflicts. Product sales, which are more equally tied to North America and international activity, were $34.2 million for the quarter, up over 3% sequentially and relatively flat from last year. Sequentially, product sales increased 18% in the U.S., primarily driven by improved market penetration of our completion products. This sequential growth in product sales in the U.S. was offset by a lower level of product sales into international markets and the Canadian market as a result of typical seasonal decline. Moving on to cost of services, ex-items for the quarter was approximately 78% of service revenue, up slightly from 77% in the prior quarter and 76% last year. As we discussed during our last call, in February, a fire damaged one of our buildings on the campus of our advanced technology center in Aberdeen. Although our insurance programs are reimbursing as for operating costs and additional costs associated with remediation of the equipment and the facility, the $1.3 million of associated insurance is recorded as other income and not reflected in cost of services or revenue. For the remainder of 2024, we project service revenue to continue growing with strong incremental margins. Cost of sales ex-items in the second quarter was 82% of revenue, improved from 93% last quarter and 84% from last year. As mentioned by Larry, the sequential improvement was primarily driven by savings from cost reduction initiatives and manufacturing efficiencies implemented at the end of the prior quarter. The company will continue to manage the business as efficiently as possible due to continued volatility in the U.S. market as onshore completion activity in the U.S. has shown signs of softening as we exited the second quarter and starting the third quarter of this year. G&A ex-items for the quarter was $10.3 million, an increase from the prior quarter, which was $8.3 million. The sequential increase in G&A expense was primarily due to the change in value of company-owned life insurance investments, which was a loss this quarter versus a gain in the prior quarter. Additionally, the company initiated a third-party assessment of our cybersecurity environment and also implementation of a global human capital management system, which increased G&A expense in the second quarter of 2024. For 2024, we expect G&A ex-items to be approximately $40 million to $42 million. It is also important to note that 100% of our corporate G&A expenses are allocated and absorbed into the financial performance of the reported segments. The operating margins in both of our segments improved this quarter compared to the first quarter of this year and the expansion of operating profit in both segments include the absorption of the $2 million increase in G&A expenses this quarter. Depreciation and amortization for the quarter was $3.8 million, flat compared to last year – last quarter. EBIT ex-items for the quarter, was $16.4 million and increased 10% from $14.9 million last quarter, yielding an EBIT margin of approximately 13%. EBIT margins are up from 12% last quarter and year-over-year. Our operating income for the quarter on a GAAP basis was $16 million. Interest expense of $3.2 million decreased from $3.4 million last quarter. The decrease was primarily due to lower average borrowings on the credit facility this quarter. Income tax expense and an effective tax rate of 20% and ex items was $2.6 million for the quarter. On a GAAP basis, we recorded a tax expense of $3.6 million for the quarter. The effective tax rate will continue to be somewhat sensitive to the geographic mix of earnings across the globe and the impact of items discrete to each quarter. We continue to project the company’s effective tax rate to be approximately 20%. Net income ex-items for the quarter was $10.4 million, an increase of over 16% from $8.9 million last quarter and up from $9.8 million in the second quarter of last year. On a GAAP basis, we recorded net income of $9 million for the quarter. Earnings per diluted share ex-items was $0.22 for the quarter, up from $0.19 in the prior quarter and $0.21 in the same quarter last year. On a GAAP basis, earnings per diluted share was $0.19 for the quarter. Turning to the balance sheet. Receivables were $115.6 million and increased slightly from $115.1 million last quarter end. Our DSOs for the second quarter were at 75 days, up slightly from the 74 days last quarter. We anticipate our DSOs will improve in future quarters. Inventory at June 30, 2024 was $69.9 million, down approximately $800,000 from last quarter end. Inventory turns have also shown some slight improvement over the last few quarters. We continue to focus our efforts on reducing the amount of inventory we are currently carrying and anticipate inventory turns will gradually improve and inventory levels to decline as we progress through the remainder of 2024. On to the liability side of the balance sheet, our long-term debt was $150 million at the end of the second quarter of 2024 and considering cash of $17.7 million, net debt was $132.3 million, which decreased $15.8 million or over 10% from the last quarter. Free cash flow generated during the quarter was primarily used to reduce debt. Our leverage ratio was reduced to 1.66 at June 30 from 1.76 last quarter end. This quarter marks the lowest level of leverage the company has maintained since the end of 2018, and we anticipate the leverage ratio will continue to improve during the remainder of 2024. Our debt is currently comprised of our senior notes at $110 million and $40 million outstanding under the bank credit facility. Our credit facility has a borrowing capacity of $135 million, of which approximately $85 million was still available as of June 30, 2024. The company will continue applying free cash towards reducing debt until the company reaches its target leverage ratio of 1.5 or lower. Looking at cash flow for the second quarter of 2024, cash flow from operating activities was approximately $17.2 million. And after paying for $2.9 million of CapEx, our free cash flow for the quarter was $14.3 million. When we compare free cash flow of $16.8 million generated by the company for the first half of this year to $1.2 million generated last year, we are pleased with not only an improvement in cash generation, but also managing the excess inventory levels down. As we indicated in our last call, we expect CapEx to modestly expand in 2024 compared to 2023 and we will continue to manage investment in working capital during a period of growth. Additionally, we expect CapEx to remain aligned with activity levels. And for the full year 2024, we expect capital expenditures to be in the range of $12 million to $14 million. Core will continue its strict capital discipline and asset-light business model with capital expenditure primarily targeted at growth opportunities. Core Lab’s operational leverage continues to provide the ability to grow revenue and profitability with minimal capital requirements. Capital expenditures have historically ranged from 2.5% to 4% of revenue even during periods of significant growth. Although we have improved the efficiencies in our global laboratory infrastructure through some consolidation of facilities, that same intellectual property and leverage exists in the business today. We believe evaluating a company’s ability to generate free cash flow and free cash flow yield is an important metric for shareholders when comparing and projecting company’s financial results, particularly for those shareholders who utilize discounted cash flow models to assess valuations. I will now turn it over to Gwen for an update on our guidance and outlook.